Recurrent Anterior Chamber Migration of Intravitreal Triamcinolone Following Scleral‐Fixated IOL Implantation
Yuki Takagi, Sho Yokoyama, Kazunori Takeuchi
TL;DR
This paper discusses how triamcinolone can move into the front of the eye after a specific type of lens implant, causing increased eye pressure.
Contribution
The paper highlights a novel clinical observation about triamcinolone migration in eyes with scleral-fixated IOLs.
Findings
Intravitreal triamcinolone can migrate into the anterior chamber after scleral-fixated IOL implantation.
This migration can cause early-onset elevation of intraocular pressure (IOP).
Abstract
In eyes with a scleral‐fixated IOL, intravitreal triamcinolone may migrate into the anterior chamber, resulting in early‐onset elevation of IOP, even at small volumes. Prompt slit lamp and gonioscopic evaluation is recommended for patients with prior vitrectomy or posterior capsule defects to ensure timely detection and treatment.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal and Macular Surgery · Retinal Diseases and Treatments · Intraocular Surgery and Lenses